Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.76 USD | -1.98% | -0.53% | +11.18% |
05-13 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
05-10 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
- Stock Market
- Equities
- SLNO Stock
- News Soleno Therapeutics, Inc.
- MarketScreener Editorial Features